Morally Regulating Innovation: What is 'Commercial Exploitation'?

Research output: Contribution to journalArticle

Abstract

Discusses the circumstances in which a European patent may be refused for a biotechnological invention because of concern about the morality of the invention, focusing on the meaning of commercial exploitation in this context. Reviews case law, considering whether the research methods used to develop the invention, the potential use of the invention, and the exclusivity and monopoly which the applicant seeks may be subject to scrutiny.
LanguageEnglish
Pages193-212
JournalIntellectual Property Quarterly
Volume2
Publication statusPublished - 2008
Externally publishedYes

Fingerprint

invention
exploitation
innovation
case law
monopoly
applicant
patent
morality
research method

Cite this

@article{61f0803a7bb44d059daa72e6bc8de501,
title = "Morally Regulating Innovation: What is 'Commercial Exploitation'?",
abstract = "Discusses the circumstances in which a European patent may be refused for a biotechnological invention because of concern about the morality of the invention, focusing on the meaning of commercial exploitation in this context. Reviews case law, considering whether the research methods used to develop the invention, the potential use of the invention, and the exclusivity and monopoly which the applicant seeks may be subject to scrutiny.",
keywords = "Biotechnology, European patents, morality, patentability",
author = "Amanda Warren-Jones",
year = "2008",
language = "English",
volume = "2",
pages = "193--212",
journal = "Intellectual Property Quarterly",
issn = "1364-906X",
publisher = "Sweet and Maxwell Ltd.",

}

Morally Regulating Innovation : What is 'Commercial Exploitation'? / Warren-Jones, Amanda.

In: Intellectual Property Quarterly, Vol. 2, 2008, p. 193-212.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Morally Regulating Innovation

T2 - Intellectual Property Quarterly

AU - Warren-Jones, Amanda

PY - 2008

Y1 - 2008

N2 - Discusses the circumstances in which a European patent may be refused for a biotechnological invention because of concern about the morality of the invention, focusing on the meaning of commercial exploitation in this context. Reviews case law, considering whether the research methods used to develop the invention, the potential use of the invention, and the exclusivity and monopoly which the applicant seeks may be subject to scrutiny.

AB - Discusses the circumstances in which a European patent may be refused for a biotechnological invention because of concern about the morality of the invention, focusing on the meaning of commercial exploitation in this context. Reviews case law, considering whether the research methods used to develop the invention, the potential use of the invention, and the exclusivity and monopoly which the applicant seeks may be subject to scrutiny.

KW - Biotechnology

KW - European patents

KW - morality

KW - patentability

UR - https://login.westlaw.co.uk/maf/wluk/app/document?&srguid=i0ad832f100000169000a25abc61408ba&docguid=I3D484E50164B11DD8890F5AFAA9E7F2E&hitguid=I3D484E50164B11DD8890F5AFAA9E7F2E&rank=5&spos=5&epos=5&td=13&crumb-action=append&context=31&resolvein=true

UR - https://www.sweetandmaxwell.co.uk/Catalogue/ProductDetails.aspx?recordid=380&productid=6791

M3 - Article

VL - 2

SP - 193

EP - 212

JO - Intellectual Property Quarterly

JF - Intellectual Property Quarterly

SN - 1364-906X

ER -